ENDRA Life Sciences prices $3.8 million private placement at $6.57 per share with warrants

ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc.

NDRA

0.00

  • ENDRA Life Sciences entered a private placement to sell 578,387 shares of common stock and/or prefunded warrants to an accredited investor.
  • The deal includes common warrants to buy up to 1,156,774 shares at USD 6.57 per share; securities priced at USD 6.57 per share.
  • Gross proceeds expected at about USD 3.8 million; closing expected May 28, 2026.
  • Use of proceeds earmarked for working capital and general corporate purposes, subject to restrictions in a side letter.
  • Some warrant exercisability requires stockholder approval; Lucid Capital Markets served as sole placement agent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-061701), on May 28, 2026, and is solely responsible for the information contained therein.